Earnings ·
Inspire Medical Systems reported second quarter 2026 revenue of $200.6 million, a 7.6% decrease from the prior year…
INSPInspire Medical Systems, Inc.
Inspire Medical Systems reported second quarter 2026 revenue of $200.6 million, a 7.6% decrease from the prior year period, driven by U.S. headwinds in coding and reimbursement partially offset by international growth. The company raised its full-year 2026 revenue guidance to $835–$875 million and adjusted diluted EPS guidance to $1.05–$1.45. Management announced Project Horizon, a strategic restructuring plan expected to incur $20–$25 million in pre-tax charges to generate approximately $30 million in annualized growth investment capacity. Inspire Medical Systems operates in the medical technology industry, developing and commercializing minimally invasive neurostimulation solutions for obstructive sleep apnea.